Sec. 60-2.2. Omissions from the list of safe, effective and therapeutically equivalent prescription drugs

The omission of a drug product from the list of drug products in no way automatically implies that such product is known to be therapeutically nonequivalent to other similar products nor that it is ineffective. Such omission shall indicate that an appropriate bioequivalence standard for all pharmaceutical equivalents of such drug has not yet been established, or that appropriate evidence that the standard has been met by such product has not been submitted to the Food and Drug Administration.